Director, Health Economic and Outcomes ResearchWho We Are Our Commercial organization leads our global sales and marketing strategies around the world. Our integrated team continues to solidify BioMarin's commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific.
SUMMARY DESCRIPTION
This role will lead the payer evidence strategy and execution for BioMarin's pipeline programs. Key activities include:
Lead development of the global payer evidence strategy
Lead HEOR evidence generation, synthesis and dissemination projects in collaboration with other functions including Clinical Sciences, Medical Affairs and Data Science
Shape the understanding of value of BioMarin's early development programs and input the market access perspective into clinical development plans to ensure they meet payer needs
RESPONSIBILITIES
Plan, develop, synthesize and disseminate HEOR evidence to demonstrate the value of BioMarin's pipeline assets
Represent market access in global cross-functional forums including the Integrated Evidence Team
Review clinical development plans including trial design, endpoints and analytical strategies to ensure they meet payer needs
Maintain knowledge of health technology assessment (HTA) policy and continue innovation in approaches to HTA in rare diseases
SCOPEThe role is part of the Global HEOR team which sits within Global Value Access & Strategic Pricing. It will
About the role Who We Are Our Commercial organization leads our global sales and marketing strategies around the world. Our integrated team continues to solidify BioMarin's commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific.
SUMMARY DESCRIPTION
This role will lead the payer evidence strategy and execution for BioMarin's pipeline programs. Key activities include:
Lead development of the global payer evidence strategy
Lead HEOR evidence generation, synthesis and dissemination projects in collaboration with other functions including Clinical Sciences, Medical Affairs and Data Science
Shape the understanding of value of BioMarin's early development programs and input the market access perspective into clinical development plans to ensure they meet payer needs
RESPONSIBILITIES
Plan, develop, synthesize and disseminate HEOR evidence to demonstrate the value of BioMarin's pipeline assets
Represent market access in global cross-functional forums including the Integrated Evidence Team
Review clinical development plans including trial design, endpoints and analytical strategies to ensure they meet payer needs
Maintain knowledge of health technology assessment (HTA) policy and continue innovation in approaches to HTA in rare diseases
SCOPEThe role is part of the Global HEOR team which sits within Global Value Access & Strategic Pricing. It will
Read more
BioMarin Pharmaceutical is open forThe story Our culture revolves around the ethos that no disease should go untreated, and our people are driven to discover, develop, and commercialize medicines that give patients, their families, and their caregivers hope where there was little or none.
There are 1001+ employees in the company
500M+ 500M+ Company annual revenue
ProductBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates.
Approved products include Naglazyme (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.
Offices The company's office is headquartered in US with additional offices located in Ireland, UK, Netherlands, Brazil, Hong Kong and Japan.
San RafaelDublinLondonHong KongTokyo Team events Learn more about BioMarin Pharmaceutical BioMarin Pharmaceutical serves clients from United States, United Kingdom, Brazil, Netherlands, Japan, Ireland.
Director, Health Economic and Outcomes Research - BioMarin Pharmaceutical - San Rafael, US
#J-18808-Ljbffr
